Page URL:

Criticism mounts on proposed NIH stem cell guidelines

1 June 2009
Appeared in BioNews 510

New proposed embryonic stem cell (ES cell) research guidelines in the US are coming under fire from critics who are concerned that the rules will in fact hamper research in this area. The National Institutes of Health (NIH) has collected over 20,000 responses to its public consultation on new stem cell research guidelines, among which are many prominent scientists who are calling for it to revisit the guidelines.

The guidelines will implement an executive order (EO-13505) issued by President Obama on 9 March 2009. The NIH proposes to fund research on embryos, but only on those which have been donated following infertility treatment. Further, it is imposing a stringent consent procedure that many commentators are worried will render many of the 21 cell lines currently eligible for funding under ex-President Bush's policy out of bounds.

'We're very concerned,' said Amy Comstock Rick from the Coalition for the Advancement of Medical Research (CAMR), which has been campaigning for a more permissive federal policy on ES cell research. She added: 'If they don't change this, very little current research would be eligible. It's a huge issue.'

It appears that under the guidelines, which are currently in provisional form, donors will have to undergo formal consent procedures with strict rules on documentation. Although consent procedures were followed by researchers prior to this, there was no uniform criteria in this area and practices differed considerably. 'It's not that past practices were shoddy... but they don't necessarily meet every letter of the new guidelines,' said Lawrence Goldstein, a stem cell researcher at the University of California. 'We'd have to throw everything out and start all over again,' he added.

George Q Daley of the Harvard Stem Cell Institute agreed, saying that the NIH has moved the 'goal posts'. 'They take 2009 standards and attempt to apply them retroactively, which isn't really a standard that would allow most of the pre-existing lines to be acceptable for NIH funding,' he said. Exactly how many cell lines might be affected is not known.

Critics are calling on the NIH to reconsider the guidelines to address these issues. Raynard S Kingston, acting director of the NIH, has said the he is aware of the concerns but that will taken them into consideration with all the other responses to the consultation.

The public consultation closed on 26 May 2009. The NIH is expected to release the finalised guidelines on 7 July 2009.

Draft National Institutes of Health Guidelines for Human Stem Cell Research
|  17 October 2021
New Rules on Stem Cells Threaten Current Research
The Washington Post |  25 May 2009
Stem cell research threatened by rules
United Press |  25 May 2009
12 December 2011 - by Victoria Kay 
The world's first 'clinical grade' human embryonic stem cells have been donated to the UK Stem Cell Bank (UKSCB). The high quality cell lines are expected to become the gold standard for developing new cell-based therapies for serious medical conditions, including spinal cord injuries...
4 May 2010 - by Dr Nadeem Shaikh 
US-based scientists working on embryonic stem cell (ES cell) research are relieved that the most important cell lines in their field have been approved for research by new government guidelines. During the Bush administration, US government funding for research involving ES cells was restricted to just 20 cell lines, all of which were in existence before 9 August 2001...
28 September 2009 - by Nienke Korsten 
The US National Institutes of Health (NIH) has launched a website through which scientists can request their human Embryonic stem (ES) cell lines to be approved for federally funded research. Eligible lines will appear on the NIH Human Embryonic Stem Cell Registry, also accessible online. Dr Francis Collins, Director of the NIH, has appointed a working group to assist him in deciding which lines will be approved....
27 April 2009 - by Antony Starza-Allen 
The Obama administration has announced its proposals to fund embryonic stem (ES) cell research but it has indicated that federal funding will be restricted to research on cell lines derived from 'surplus' embryos donated following IVF procedures. Mr Obama reversed former President Bush's restriction on federal funding...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.